G Zilidis1, F Aziz, S Telara, M Sam Eljamel. 1. Department of Neurosurgery, Ninewells Hospital and Medical School, Dundee, Scotland, UK. sam.eljamel@btinternet.com
Abstract
UNLABELLED: Metastatic brain melanoma occurs in about 3.5% of patients suffering from malignant melanoma. It has disabling effects on cognition, memory, language and mobility. We studied the use of fluorescence image-guided resection and repetitive Photodynamic Therapy in six consecutive metastatic brain melanomas. Three were males and the mean age of the group was 52.8 years. RESULTS: All six patients (100%) remained free of brain disease till death, 50% died of malignant melanoma elsewhere, and 50% died of unrelated causes. CONCLUSION: Adjuvant fluorescence image-guided resection and repetitive Photodynamic Therapy offers an excellent local control of metastatic brain melanoma.
UNLABELLED: Metastatic brain melanoma occurs in about 3.5% of patients suffering from malignant melanoma. It has disabling effects on cognition, memory, language and mobility. We studied the use of fluorescence image-guided resection and repetitive Photodynamic Therapy in six consecutive metastatic brain melanomas. Three were males and the mean age of the group was 52.8 years. RESULTS: All six patients (100%) remained free of brain disease till death, 50% died of malignant melanoma elsewhere, and 50% died of unrelated causes. CONCLUSION: Adjuvant fluorescence image-guided resection and repetitive Photodynamic Therapy offers an excellent local control of metastatic brain melanoma.
Authors: Joseph A Spernyak; William H White; Manivannan Ethirajan; Nayan J Patel; Lalit Goswami; Yihui Chen; Steven Turowski; Joseph R Missert; Carrie Batt; Richard Mazurchuk; Ravindra K Pandey Journal: Bioconjug Chem Date: 2010-05-19 Impact factor: 4.774
Authors: Abraham S Moses; Olena R Taratula; Hyelim Lee; Fangzhou Luo; Tanner Grenz; Tetiana Korzun; Anna St Lorenz; Fahad Y Sabei; Shay Bracha; Adam W G Alani; Ov D Slayden; Oleh Taratula Journal: Small Date: 2020-04-06 Impact factor: 13.281
Authors: A C Weems; J E Raymond; A D Easley; M A Wierzbicki; T Gustafson; Mbb Monroe; D J Maitland Journal: RSC Adv Date: 2017-04-04 Impact factor: 3.361